Article
Procedures for the GMP-Compliant Production and Quality Control of [<sup>18</sup>F]PSMA-1007—A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer
2017-08-17
Abstract excerpt
Radiolabelled tracers targeting the prostate-specific membrane antigen (PSMA) have become important radiopharmaceuticals for the PET-imaging of prostate cancer. In this connection we recently developed the fluorine-18 labelled PSMA-ligand [18F]PSMA-1007 as next generation radiofluorinated Glu-ureido PSMA inhibitor after [18F]DCFPyL and [18F]DCFBC. Since radiosynthesis so far was suffering for rather poor yields no...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8862bbc9-2916-5900-861c-ada37e885898
- DOI
- 10.20944/preprints201708.0057.v1
